|
Thursday 31st March 2022 |
Text too small? |
Cannasouth Limited (NZX: CBD , Cannasouth), today released its Annual Report for the year ended 31 December 2021.
Changes versus 2021 Unaudited Preliminary Results
On 1 March 2022 Cannasouth released to the market its preliminary results for the year ended 31 December 2021 (Preliminary Results). The table in the attached '2021 Annual Report Announcement' document summarises the key results.
The Preliminary Results were prepared on the basis that the accounting treatment for the acquisition of Midwest Pharmaceutics NZ Ltd and Cannasouth Cultivation Ltd was subject to audit. The reclassification of pre-acquisition transactions has no cash flow impacts.
Included with this announcement are the following documents:
• 2021 Annual Report
• Revised Results Announcement Form
-ENDS-
No comments yet
GEN - General Capital gives Notice of Annual Meeting 2026
AFT Chair David Flacks to retire before the next ASM
PCT - Precinct NZ $65 million Wholesale Bond Issue
FRW - Chair Announces Appointment of Successor
PCT - Future Director Appointment
FRW - Chair Announces Appointment of Successor
Me Today Market Update
IKE 1Q FY27 Performance Update
BPG - Q1 FY27 Trading Update
AFT R&D Portfolio Offers Multi-$bn Market Potential